Alcohol withdrawal requiring massive prolonged benzodiazepine infusion

被引:5
|
作者
Hayes, Patrick C.
Faestel, Paul M.
Shimamoto, Paige L.
Holland, J. Craig
机构
[1] Tripler Army Med Ctr, Dept Psychiat, Honolulu, HI 96859 USA
[2] Tripler Army Med Ctr, Dept Med, Honolulu, HI 96859 USA
[3] Tripler Army Med Ctr, Dept Pharm, Honolulu, HI 96859 USA
关键词
D O I
10.7205/MILMED.172.5.556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this case report is to describe a patient with prolonged alcohol withdrawal requiring massive standing doses of benzodiazepines. The setting is the medical intensive care unit of the Tripler Army Medical Center, Honolulu, Hawaii. The patient is a 58-year-old alcohol-dependent male presenting with mental status changes and agitation following an uncomplicated cystoprostatectomy, who ultimately required massive doses of benzodiazepines to treat his symptoms effectively. We conclude that symptom-triggered therapy proved ineffective in this case due to inability to achieve adequate frequency of assessments. Ultimately, a lengthy, high-dose, fixed interval benzodiazepine regimen was required. The 5-week period of intensive care illustrated that scheduled doses of benzodiazepines may be required and massive and prolonged doses are sometimes necessary. Adherence to a slow-weaning protocol understood by an interdisciplinary team was critical to this patient's recovery. Additionally, toxicity from the high-dose medication was not observed.
引用
收藏
页码:556 / 559
页数:4
相关论文
共 50 条
  • [41] Phenobarbital and benzodiazepine assisted withdrawal of prolonged pentobarbital treatment for refractory status epilepticus
    Krishnamurthy, KB
    Drislane, FW
    JOURNAL OF EPILEPSY, 1997, 10 (05): : 211 - 214
  • [42] Benzodiazepine resistant alcohol withdrawal: What is the clinician's preferred definition?
    Langlois, Hugo
    Cormier, Monique
    Villeneuve, Eric
    Hoffman, Robert
    Longo, Cristina
    Gosselin, Sophie
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2020, 22 (02) : 165 - 169
  • [43] Effectiveness of Gabapentin as a Benzodiazepine-Sparing Agent in Alcohol Withdrawal Syndrome
    Alzghoul, Hamza
    Al-Said, Mohammed I.
    Obeidat, Omar
    Al-Ani, Hashim
    Tarawneh, Mohammad
    Meadows, Robyn
    Youness, Houssein
    Reddy, Raju
    Al-Jafari, Mohammad
    Alzghoul, Bashar N.
    Khan, Akram
    MEDICINA-LITHUANIA, 2024, 60 (06):
  • [44] A META-ANALYSIS OF BENZODIAZEPINE USE IN PREVENTING ALCOHOL WITHDRAWAL SEIZURES
    OCONNOR, PG
    HORWITZ, RI
    CLINICAL RESEARCH, 1988, 36 (03): : A348 - A348
  • [45] Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal
    Holbrook, AM
    Crowther, R
    Lotter, A
    Cheng, CC
    King, D
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1999, 160 (05) : 649 - 655
  • [46] ANALYZING A MODIFIED ALCOHOL WITHDRAWAL PROTOCOL WITH PHENOBARBITAL DURING A BENZODIAZEPINE SHORTAGE
    Fussell-Louie, David
    Li, Irene
    Forni, Allison
    CRITICAL CARE MEDICINE, 2020, 48
  • [47] Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series
    Hulse, Gary
    O'Neil, George
    Morris, Noella
    Bennett, Kellie
    Norman, Amanda
    Hood, Sean
    JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (02) : 222 - 227
  • [48] Continuous infusion flumazenil for prolonged benzodiazepine-induced sedation: a case report
    Nelson, Sarah
    Schiavo, Dante
    Oeckler, Richard
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [49] Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal
    Multz, AS
    ANESTHESIA AND ANALGESIA, 2003, 96 (04): : 1054 - 1055
  • [50] RAPID AND SAFE WITHDRAWAL OF INTRAVENOUS PAPAVERETUM AFTER PROLONGED CONTINUOUS INFUSION
    MORGAN, RJM
    ANAESTHESIA, 1983, 38 (05) : 492 - 494